Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-15

Clinical Trial Update: Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?

View source ↗

Summary

An ongoing clinical study is evaluating whether hepatic-splenic elastography can predict recurrence risk after radiofrequency ablation for hepatocellular carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: HCC - Hepatocellular Carcinoma | Status: RECRUITING